0001752724-24-010259.txt : 20240124 0001752724-24-010259.hdr.sgml : 20240124 20240124132254 ACCESSION NUMBER: 0001752724-24-010259 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 PERIOD START: 20240229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon ETF Trust CENTRAL INDEX KEY: 0001493580 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-23477 FILM NUMBER: 24555540 BUSINESS ADDRESS: STREET 1: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 BUSINESS PHONE: 212-922-6400 MAIL ADDRESS: STREET 1: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 FORMER COMPANY: FORMER CONFORMED NAME: Dreyfus ETF Trust DATE OF NAME CHANGE: 20100607 0001493580 S000080184 BNY Mellon Women's Opportunities ETF C000241888 BNY Mellon Women's Opportunities ETF BKWO NPORT-P 1 primary_doc.xml NPORT-P false 0001493580 XXXXXXXX S000080184 C000241888 BNY Mellon ETF Trust 811-23477 0001493580 549300E2C8EQYJ7B0H81 240 Greenwich Street New York 10286 212-922-6400 BNY Mellon Womens Opportunities ETF S000080184 549300QAQYJD1TI1DO07 2024-02-29 2023-11-30 N 10863535.30 4304.47 10859230.83 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Akamai Technologies Inc OC1LZNN2LF5WTJ5RIL89 Akamai Technologies Inc 00971T101 1517.00000000 NS USD 175259.01000000 1.613917345930 Long EC CORP US N 1 N N N Alnylam Pharmaceuticals Inc 529900S3ZI14OWRJII50 Alnylam Pharmaceuticals Inc 02043Q107 480.00000000 NS USD 80760.00000000 0.743699082046 Long EC CORP US N 1 N N N Eli Lilly & Co FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co 532457108 544.00000000 NS USD 321525.76000000 2.960852062484 Long EC CORP US N 1 N N N Danaher Corp S4BKK9OTCEWQ3YHPFM11 Danaher Corp 235851102 992.00000000 NS USD 221523.52000000 2.039955899896 Long EC CORP US N 1 N N N NVIDIA Corp 549300S4KLFTLO7GSQ80 NVIDIA Corp 67066G104 780.00000000 NS USD 364806.00000000 3.359409204123 Long EC CORP US N 1 N N N Centene Corp 549300Z7JJ4TQSQGT333 Centene Corp 15135B101 2400.00000000 NS USD 176832.00000000 1.628402626008 Long EC CORP US N 1 N N N HubSpot Inc 529900BLNVEW0MVKJB37 HubSpot Inc 443573100 470.00000000 NS USD 232147.10000000 2.137785849055 Long EC CORP US N 1 N N N Hologic Inc 549300DYP6F5ZJL0LB74 Hologic Inc 436440101 1816.00000000 NS USD 129480.80000000 1.192357009690 Long EC CORP US N 1 N N N AbbVie Inc FR5LCKFTG8054YNNRU85 AbbVie Inc 00287Y109 2248.00000000 NS USD 320092.72000000 2.947655547718 Long EC CORP US N 1 N N N Progyny Inc N/A Progyny Inc 74340E103 5520.00000000 NS USD 189667.20000000 1.746598842673 Long EC CORP US N 1 N N N Zoetis Inc 549300HD9Q1LOC9KLJ48 Zoetis Inc 98978V103 570.00000000 NS USD 100701.90000000 0.927339160355 Long EC CORP US N 1 N N N Procter & Gamble Co/The 2572IBTT8CCZW6AU4141 Procter & Gamble Co/The 742718109 1165.00000000 NS USD 178850.80000000 1.646993261308 Long EC CORP US N 1 N N N JPMorgan Chase & Co 8I5DZWZKVSZI1NUHU748 JPMorgan Chase & Co 46625H100 2416.00000000 NS USD 377089.28000000 3.472522924535 Long EC CORP US N 1 N N N Schlumberger NV 213800ZUA17OK3QLGM62 Schlumberger NV 806857108 3384.00000000 NS USD 176103.36000000 1.621692758510 Long EC CORP US N 1 N N N Mastercard Inc AR5L2ODV9HN37376R084 Mastercard Inc 57636Q104 784.00000000 NS USD 324442.72000000 2.987713633489 Long EC CORP US N 1 N N N PepsiCo Inc FJSUNZKFNQ5YPJ5OT455 PepsiCo Inc 713448108 1288.00000000 NS USD 216757.52000000 1.996066971899 Long EC CORP US N 1 N N N Cooper Cos Inc/The QJKMVPIGLH7530PCUE20 Cooper Cos Inc/The 216648402 413.00000000 NS USD 139147.96000000 1.281379521057 Long EC CORP US N 1 N N N Exelon Corp 3SOUA6IRML7435B56G12 Exelon Corp 30161N101 4896.00000000 NS USD 188544.96000000 1.736264409069 Long EC CORP US N 1 N N N Bright Horizons Family Solutio N/A Bright Horizons Family Solutions Inc 109194100 2826.00000000 NS USD 247105.44000000 2.275533542553 Long EC CORP US N 1 N N N Dreyfus Institutional Preferred Government Money Market Fund 549300RBWL04JG8SIX57 Dreyfus Institutional Preferred Government Money Market Fund 000000000 162893.64000000 NS USD 162893.64000000 1.500047678791 Long STIV RF US N 1 N N N Boston Scientific Corp Y6ZDD9FP4P8JSSJMW954 Boston Scientific Corp 101137107 4676.00000000 NS USD 261341.64000000 2.406631225464 Long EC CORP US N 1 N N N Caterpillar Inc WRJR7GS4GTRECRRTVX92 Caterpillar Inc 149123101 420.00000000 NS USD 105302.40000000 0.969704039342 Long EC CORP US N 1 N N N Shopify Inc 549300HGQ43STJLLP808 Shopify Inc 82509L107 4488.00000000 NS USD 326816.16000000 3.009570061786 Long EC CORP CA N 1 N N N Omnicom Group Inc HKUPACFHSSASQK8HLS17 Omnicom Group Inc 681919106 1714.00000000 NS USD 138199.82000000 1.272648331760 Long EC CORP US N 1 N N N Bank of America Corp 9DJT3UXIJIZJI4WXO774 Bank of America Corp 060505104 3648.00000000 NS USD 111227.52000000 1.024267019840 Long EC CORP US N 1 N N N Workday Inc 549300J0DYC0N31V7G13 Workday Inc 98138H101 720.00000000 NS USD 194918.40000000 1.794955858765 Long EC CORP US N 1 N N N Applied Materials Inc 41BNNE1AFPNAZELZ6K07 Applied Materials Inc 038222105 1335.00000000 NS USD 199956.30000000 1.841348647342 Long EC CORP US N 1 N N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina Inc 452327109 1352.00000000 NS USD 137836.40000000 1.269301685891 Long EC CORP US N 1 N N N Lululemon Athletica Inc 549300D9GZ4BMLDW5T40 Lululemon Athletica Inc 550021109 536.00000000 NS USD 239484.80000000 2.205356933185 Long EC CORP CA N 1 N N N Progressive Corp/The 529900TACNVLY9DCR586 Progressive Corp/The 743315103 1888.00000000 NS USD 309688.64000000 2.851846920358 Long EC CORP US N 1 N N N CoStar Group Inc N/A CoStar Group Inc 22160N109 1779.00000000 NS USD 147728.16000000 1.360392483709 Long EC CORP US N 1 N N N Alcoa Corp 549300T12EZ1F6PWWU29 Alcoa Corp 013872106 3318.00000000 NS USD 89121.48000000 0.820697905728 Long EC CORP US N 1 N N N Intuit Inc VI90HBPH7XSFMB9E4M29 Intuit Inc 461202103 496.00000000 NS USD 283444.16000000 2.610167924757 Long EC CORP US N 1 N N N FedEx Corp 549300E707U7WNPZN687 FedEx Corp 31428X106 1104.00000000 NS USD 285748.32000000 2.631386370483 Long EC CORP US N 1 N N N Walt Disney Co/The 549300GZKULIZ0WOW665 Walt Disney Co/The 254687106 1248.00000000 NS USD 115677.12000000 1.065242297644 Long EC CORP US N 1 N N N Meta Platforms Inc BQ4BKCS1HXDV9HN80Z93 Meta Platforms Inc 30303M102 806.00000000 NS USD 263682.90000000 2.428191316014 Long EC CORP US N 1 N N N Constellium SE 724500KRJEMC79KAAU28 Constellium SE 000000000 5856.00000000 NS USD 101894.40000000 0.938320601110 Long EC CORP FR N 1 N N N Accenture PLC 5493000EWHDSR3MZWH98 Accenture PLC 000000000 761.00000000 NS USD 253519.54000000 2.334599420242 Long EC CORP IE N 1 N N N Trane Technologies PLC 549300BURLR9SLYY2705 Trane Technologies PLC 000000000 848.00000000 NS USD 191147.68000000 1.760232220793 Long EC CORP IE N 1 N N N Veralto Corp 635400FJE6GSOJUSNY27 Veralto Corp 92338C103 1031.00000000 NS USD 79644.75000000 0.733429017642 Long EC CORP US N 1 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 Amazon.com Inc 023135106 4280.00000000 NS USD 625265.20000000 5.757914255516 Long EC CORP US N 1 N N N Uber Technologies Inc 549300B2FTG34FILDR98 Uber Technologies Inc 90353T100 6040.00000000 NS USD 340535.20000000 3.135905344780 Long EC CORP US N 1 N N N Texas Instruments Inc WDJNR2L6D8RWOEB8T652 Texas Instruments Inc 882508104 756.00000000 NS USD 115448.76000000 1.063139386272 Long EC CORP US N 1 N N N ConocoPhillips WPTL2Z3FIYTHSP5V2253 ConocoPhillips 20825C104 1012.00000000 NS USD 116956.84000000 1.077026926040 Long EC CORP US N 1 N N N Block Inc 549300OHIIUWSTIZME52 Block Inc 852234103 1784.00000000 NS USD 113159.12000000 1.042054651673 Long EC CORP US N 1 N N N Addus HomeCare Corp 52990090ZT33AKPDBX62 Addus HomeCare Corp 006739106 1152.00000000 NS USD 100454.40000000 0.925059993406 Long EC CORP US N 1 N N N Occidental Petroleum Corp IM7X0T3ECJW4C1T7ON55 Occidental Petroleum Corp 674599105 2773.00000000 NS USD 164022.95000000 1.510447218295 Long EC CORP US N 1 N N N ANSYS Inc 549300VJV8H15Z5FJ571 ANSYS Inc 03662Q105 588.00000000 NS USD 172495.68000000 1.588470516009 Long EC CORP US N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 Microsoft Corp 594918104 2496.00000000 NS USD 945759.36000000 8.709266565982 Long EC CORP US N 1 N N N 2024-01-17 BNY Mellon ETF Trust James Windels James Windels Treasurer XXXX NPORT-EX 2 647974BNYM113023.htm
STATEMENT
OF
INVESTMENTS
November
30,
2023
(Unaudited)
1
Description
Shares
Value
($)
Common
Stocks
98.5%
Banks
4.5%
Bank
of
America
Corp.
3,648
111,228
JPMorgan
Chase
&
Co.
2,416
377,089
488,317
Capital
Goods
2.7%
Caterpillar,
Inc.
420
105,302
Trane
Technologies
PLC
848
191,148
296,450
Commercial
&
Professional
Services
0.7%
Veralto
Corp.
(a)
1,031
79,645
Consumer
Discretionary
Distribution
&
Retail
5.8%
Amazon.com,
Inc.
(a)
4,280
625,265
Consumer
Durables
&
Apparel
2.2%
Lululemon
Athletica,
Inc.
(a)
536
239,485
Consumer
Services
2.3%
Bright
Horizons
Family
Solutions,
Inc.
(a)
2,826
247,105
Energy
4.2%
ConocoPhillips
1,012
116,957
Occidental
Petroleum
Corp.
2,773
164,023
Schlumberger
NV
3,384
176,103
457,083
Financial
Services
4.0%
Block,
Inc.
(a)
1,784
113,159
Mastercard,
Inc.,
Class
A
784
324,443
437,602
Food,
Beverage
&
Tobacco
2.0%
PepsiCo,
Inc.
1,288
216,758
Health
Care
Equipment
&
Services
9.2%
Addus
Homecare
Corp.
(a)
1,152
100,454
Boston
Scientific
Corp.
(a)
4,676
261,342
Centene
Corp.
(a)
2,400
176,832
Cooper
Cos.,
Inc.
(The)
413
139,148
Hologic,
Inc.
(a)
1,816
129,481
Progyny,
Inc.
(a)
5,520
189,667
996,924
Household
&
Personal
Products
1.6%
Procter
&
Gamble
Co.
(The)
1,165
178,851
STATEMENT
OF
INVESTMENTS
(continued)
2
Description
Shares
Value
($)
Common
Stocks
98.5%
(continued)
Insurance
2.8%
Progressive
Corp.
(The)
1,888
309,689
Materials
1.8%
Alcoa
Corp.
3,318
89,122
Constellium
SE
(a)
5,856
101,894
191,016
Media
&
Entertainment
4.8%
Meta
Platforms,
Inc.,
Class
A
(a)
806
263,683
Omnicom
Group,
Inc.
1,714
138,200
Walt
Disney
Co.
(The)
(a)
1,248
115,677
517,560
Pharmaceuticals,
Biotechnology
&
Life
Sciences
10.9%
AbbVie,
Inc.
2,248
320,093
Alnylam
Pharmaceuticals,
Inc.
(a)
480
80,760
Danaher
Corp.
992
221,523
Eli
Lilly
&
Co.
544
321,526
Illumina,
Inc.
(a)
1,352
137,836
Zoetis,
Inc.
570
100,702
1,182,440
Real
Estate
Management
&
Development
1.4%
CoStar
Group,
Inc.
(a)
1,779
147,728
Semiconductors
&
Semiconductor
Equipment
6.3%
Applied
Materials,
Inc.
1,335
199,956
NVIDIA
Corp.
780
364,806
Texas
Instruments,
Inc.
756
115,449
680,211
Software
&
Services
23.8%
Accenture
PLC,
Class
A
761
253,520
Akamai
Technologies,
Inc.
(a)
1,517
175,259
ANSYS,
Inc.
(a)
588
172,496
HubSpot,
Inc.
(a)
470
232,147
Intuit,
Inc.
496
283,444
Microsoft
Corp.
2,496
945,759
Shopify,
Inc.,
Class
A
(a)
4,488
326,816
Workday,
Inc.,
Class
A
(a)
720
194,918
2,584,359
Transportation
5.8%
FedEx
Corp.
1,104
285,748
Uber
Technologies,
Inc.
(a)
6,040
340,535
626,283
Utilities
1.7%
Exelon
Corp.
4,896
188,545
Total
Common
Stocks
(cost
$9,717,886)
10,691,316
3
See
Notes
to
Statement
of
Investments
Description
Shares
Value
($)
Investment
Companies
1.5%
Registered
Investment
Companies
1.5%
Dreyfus
Institutional
Preferred
Government
Money
Market
Fund,
Institutional
Shares,
5.32%
(b)(c)
(cost
$162,894)
162,894
162,894
Total
Investments
(cost
$9,880,780)
100.0%
10,854,210
Cash
and
Receivables
(Net)
0.0%
5,021
Net
Assets
100.0%
10,859,231
(a)
Non-income
producing
security.
(b)
Investment
in
affiliated
issuer.
The
investment
objective
of
this
investment
company
is
publicly
available
and
can
be
found
within
the
investment
company’s
prospectus.
(c)
The
rate
shown
is
the
1-day
yield
as
of
November
30,
2023.
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
4
The
Financial
Accounting
Standards
Board
(“FASB”)
Accounting
Standards
Codification
(“ASC”)
is
the
exclusive
reference
of
authoritative
U.S.
generally
accepted
accounting
principles
(“GAAP”)
recognized
by
the
FASB
to
be
applied
by
nongovernmental
entities.
Rules
and
interpretive
releases
of
the
Securities
and
Exchange
Commission
(“SEC”)
under
authority
of
federal
laws
are
also
sources
of
authoritative
GAAP
for
SEC
registrants. BNY
Mellon
Women's
Opportunities
ETF (the
“fund”)
is an
investment
company
and
applies
the
accounting
and
reporting
guidance
of
the
FASB
ASC
Topic
946
Financial
Services-Investment
Companies. The
fund’s
financial
statements
are
prepared
in
accordance
with
GAAP,
which
may
require
the
use
of
management
estimates
and
assumptions.
Actual
results
could
differ
from
those
estimates.  
(a)
Portfolio
valuation:
The
fair
value
of
a
financial
instrument
is
the
amount
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date
(i.e.,
the
exit
price).
GAAP
establishes
a
fair
value
hierarchy
that
prioritizes
the
inputs
of
valuation
techniques
used
to
measure
fair
value.
This
hierarchy
gives
the
highest
priority
to
unadjusted
quoted
prices
in
active
markets
for
identical
assets
or
liabilities
(Level
1
measurements)
and
the
lowest
priority
to
unobservable
inputs
(Level
3
measurements).
Additionally,
GAAP
provides
guidance
on
determining
whether
the
volume
and
activity
in
a
market
has
decreased
significantly
and
whether
such
a
decrease
in
activity
results
in
transactions
that
are
not
orderly.
GAAP
requires
enhanced
disclosures
around
valuation
inputs
and
techniques
used
during
annual
and
interim
periods.
Various
inputs
are
used
in
determining
the
value
of
the
fund’s
investments
relating
to
fair
value
measurements.
These
inputs
are
summarized
in
the
three
broad
levels
listed
below:
Level
1
unadjusted
quoted
prices
in
active
markets
for
identical
investments.
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar 
investments,
interest
rates,
prepayment
speeds,
credit
risk,
etc.).
Level
3
significant
unobservable
inputs
(including
the
fund’s
own
assumptions
in
determining
the
fair
value
of
investments).
The
inputs
or
methodology
used
for
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
Changes
in
valuation
techniques
may
result
in
transfers
in
or
out
of
an
assigned
level
within
the
disclosure
hierarchy.
Valuation
techniques
used
to
value
the
fund’s
investments
are
as
follows:
5
BNY
Mellon
ETF
Trust’s
(the
“Trust”) Board
of
Trustees
(the
“Board”)
has
designated
the
Adviser
as
the
fund’s
valuation
designee
to
make
all
fair
value
determinations
with
respect
to
the
fund’s
portfolio
of
investments,
subject
to
the
Board’s
oversight
and
pursuant
to
Rule
2a-5
under
the
Act.
Investments
in
equity
securities,
including
ETFs
(but
not
including
investments
in
other
open-end
registered
investment
companies),
generally
are
valued
at
the
last
sales
price
on
the
day
of
valuation
on
the
securities
exchange
or
national
securities
market
on
which
such
securities
primarily
are
traded.
Securities
listed
on
the
National
Association
of
Securities
Dealers
Automated
Quotation
System
(“NASDAQ”)
for
which
market
quotations
are
available
will
be
valued
at
the
official
closing
price.
If
there
are
no
transactions
in
a
security,
or
no
official
closing
prices
for
a
NASDAQ
market-listed
security
on
that
day,
the
security
will
be
valued
at
the
average
of
the
most
recent
bid
and
asked
prices.
Bid
price
is
used
when
no
asked
price
is
available.
Open
short
positions
for
which
there
is
no
sale
price
on
a
given
day
are
valued
at
the
lowest
asked
price.
Registered
investment
companies
that
are
not
traded
on
an
exchange
are
valued
at
their
net
asset
value.
All
of
the
preceding
securities
are
generally
categorized
within
Level
1
of
the
fair
value
hierarchy. 
When
market
quotations
or
official
closing
prices
are
not
readily
available,
or
are
determined
not
to
reflect
fair
value
accurately,
they are
valued
at
fair
value
as
determined
in
good
faith
based
on
procedures
approved
by
the
Board.
Fair
value
of
investments
may
be
determined
by
valuation
designee
using
such
information
as
it
deems
appropriate
under
the
circumstances.
Certain
factors
may
be
considered
when
fair
valuing
investments
such
as:
fundamental
analytical
data,
the
nature
and
duration
of
restrictions
on
disposition,
an
evaluation
of
the
forces
that
influence
the
market
in
which
the
securities
are
purchased
and
sold,
and
public
trading
in
similar
securities
of
the
issuer
or
comparable
issuers.
These
securities
are
either
categorized
within
Level
2
or
3
of
the
fair
value
hierarchy
depending
on
the
relevant
inputs
used.
For
securities
where
observable
inputs
are
limited,
assumptions
about
market
activity
and
risk
are
used
and
are
generally
categorized
within
Level
3
of
the
fair
value
hierarchy.
The
table
below
summarizes
the
inputs
used
as
of November
30,
2023
in
valuing
the
fund’s
investments:
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
(continued)
6
Fair
Value
Measurements
Additional
investment
related
disclosures
are
hereby
incorporated
by
reference
to
the
semi-annual
report
previously
filed
with
the
SEC
on
Form
N-CSR.
At November
30,
2023,
accumulated
net
unrealized
appreciation on
investments
was
$973,430,
consisting
of
gross
appreciation
of
$1,282,809
and
gross
depreciation
of
$309,379.
At
November
30,
2023,
the
cost
of
investments
for
federal
income
tax
purposes
was
substantially
the
same
as
the
cost
for
financial
reporting
purposes
(see
the
Statement
of
Investments).
Level
1
-
Unadjusted
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
($)
Investments
In
Securities:
Common
Stocks
10,691,316
10,691,316
Investment
Companies
162,894
162,894
See
Statement
of
Investments
for
additional
detailed
categorizations,
if
any.